SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
BrightSpring Health Services, Inc. Common Stock (BTSG) trades at a trailing P/E of 48.5, forward P/E of 29.6. Trailing earnings yield is 2.06%, forward earnings yield 3.38%. PEG 0.38 (Peter Lynch undervalued ≤1.0). Graham Number is $14.04.
Criteria proven by this page:
- VALUE (51/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 29.6 (down from trailing 48.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.38 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 2.06% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.38% as earnings recover.
- Analyst consensus target $44.18 (-4% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 48/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
51/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BTSG
Valuation Multiples
P/E (TTM)48.5
Forward P/E29.6
PEG Ratio0.38
Forward PEG0.38
P/B Ratio4.93
P/S Ratio0.68
EV/EBITDA25.2
Per Share Data
EPS (TTM)$0.94
Forward EPS (Est.)$1.56
Book Value / Share$9.31
Revenue / Share$63.74
FCF / Share$2.42
Yields & Fair Value
Earnings Yield2.06%
Forward Earnings Yield3.38%
Dividend Yield0.00%
Graham Number$14.04
SharesGrow IV$84.83 (+84.3%)
Analyst Target$44.18 (-4%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2018 |
-247.1 |
0.00 |
0.00 |
0.74 |
- |
| 2019 |
-26.0 |
-0.03 |
2.87 |
0.42 |
- |
| 2020 |
90.5 |
-0.70 |
2.67 |
0.34 |
- |
| 2021 |
37.8 |
0.27 |
2.43 |
0.28 |
- |
| 2022 |
-34.9 |
0.17 |
2.49 |
0.24 |
- |
| 2023 |
-12.2 |
-0.06 |
3.22 |
0.21 |
- |
| 2024 |
-182.0 |
2.03 |
1.99 |
0.29 |
- |
| 2025 |
39.8 |
-0.04 |
4.05 |
0.59 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$-1.57 |
$2.54B |
$-7.62M |
-0.3% |
| 2019 |
$-10.26 |
$4.53B |
$-72.38M |
-1.6% |
| 2020 |
$2.78 |
$5.58B |
$20.81M |
0.4% |
| 2021 |
$0.29 |
$6.7B |
$49.8M |
0.7% |
| 2022 |
$-0.31 |
$7.72B |
$-53.91M |
-0.7% |
| 2023 |
$-0.90 |
$8.83B |
$-154.6M |
-1.8% |
| 2024 |
$-0.09 |
$11.27B |
$-18.06M |
-0.2% |
| 2025 |
$0.87 |
$12.91B |
$190.67M |
1.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.55 |
$1.17 – $2.26 |
$14.84B |
$14.74B – $15.01B |
10 |
| 2027 |
$1.95 |
$1.47 – $2.11 |
$16.7B |
$15.37B – $17.47B |
10 |
| 2028 |
$2.60 |
$2.27 – $3.22 |
$19.2B |
$19.2B – $19.2B |
4 |
| 2029 |
$3.61 |
$3.38 – $3.73 |
$22.98B |
$21.86B – $23.58B |
2 |
| 2030 |
$5.24 |
$4.91 – $5.42 |
$27.89B |
$26.52B – $28.6B |
2 |
